The pharmaceutical and chemical company Bayer is now also in Europe-production possibilities for the active substance chloroquine in the possible fight against the lung disease Covid-19.
Bayer CEO Werner Baumann announced on Thursday in an Interview with ‘Handelsblatt’ that the production systems should also be in Europe for the production of the drug retinal toxicity of the active substance chloroquine adapted.
so Far, the funds that want to donate Bayer in crisis, free of charge, to governments will be made only at a location in Pakistan.
already in the 1930s, developed a drug for malaria prophylaxis for a few weeks in the conversation, after Tests on cell cultures had shown an inhibition of the proliferation of the novel Coronavirus, which can cause the lung disease Covid-19.
Effect of chloroquine against the Coronavirus?
“There are indications that retinal toxicity in the laboratory and in clinical studies, lowers the viral load,” said Baumann of the sheet.
more clinical studies are necessary to clarify the ratio of Benefit and risk. This would now be started, among other things, of the world health organization WHO.
chloroquine was in March, outside of specialist circles increasingly into the conversation, after US President Donald Trump for the use of the Malaria drug in the treatment of Covid-19-had recruited Patients.
experts are in view of possible side-effects but be careful and warn against self-medication. Thus, the treatment of Covid is about in France-19-Ill only be allowed in severe cases and after consultations with Doctors.
Deutsche Presse-Agentur (dpa)
*The contribution to “Against Malaria known: Covid-19-active substance is also to be published in Europe, produced” will be FitForFun. Contact with the executives here.
FitForFun
